AdvanSix Q3 2026 earnings

ASIX · 2026-11-04 06:31 BMO ET · 8-K on SEC

Sales grew 15% YoY driven by pricing, but Adjusted EBITDA and EPS declined due to reduced production output and higher raw material costs.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$431M+15%+2.4%Ex. 99.1, income statement
EPS (GAAP)$-0.28$-0.18$-0.40Ex. 99.1, income statement
EPS (adjusted)$-0.24$-0.32$-0.52Ex. 99.1, income statement
Net income$-7.6M$-4.9M$-10.8MEx. 99.1, income statement
Adj. EBITDA$14.6M$-10.1M$-17.3MEx. 99.1, income statement
Adj. EBITDA margin3.4%-320 bps-4.2 ppEx. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Plant NutrientsN/AN/AN/ASales volume declined due to challenging agricultural fundamentals; pricing improved 7%.
Nylon SolutionsN/AN/AN/ASales volume declined due to lower caprolactam sales; core operating rate exceeded global industry averages.
Chemical IntermediatesN/AN/AN/APerformed at or better than expectations.

Margins and costs

  • Gross margin N/A
  • Operating expenses $19.2M (+30.2% YoY)
  • One-offs in the quarter Strategic advisory and professional fees; Income tax benefit relating to reconciling items
  • Effective tax rate N/A
  • Non-GAAP bridge Adds back non-cash stock-based compensation ($0.68M), non-cash amortization ($0.53M), strategic advisory fees, and income tax benefits; excludes interest, taxes, depreciation, and amortization.

KPIs

MetricActualPrior quarterPrior yearChange
Cash Flow from Operations$48.0M$10.0M$26.6M+$38.0M QoQ, +$21.4M YoY
Capital Expenditures$18.3M$20.7M$26.5M-$2.4M QoQ, -$8.2M YoY
Free Cash Flow$29.7M$-10.7M$0.1M+$40.4M QoQ, +$29.6M YoY

Guidance

MetricGuidePrior guideChange
Capital Expenditures 2026$90M$75-95MLowered midpoint
Pre-tax income impact of plant turnarounds 2026$17M$17MNo change
2H 2026 sequential cash flow improvementExpectedExpectedNo change

What drove it

  • Revenue story Sales increased 15% YoY driven by 17% favorable pricing, partially offset by a 2% decline in volume; raw material pass-through pricing increased 10% and market-based pricing improved 7%.
  • EPS story Adjusted EPS declined $0.32 YoY due to reduced production output, higher raw material costs, and a higher effective tax rate.
  • One-off check Strategic advisory and professional fees ($0.0M) and income tax benefit relating to reconciling items ($0.2M) in the quarter.

The good

  • Sales grew 15% YoY driven by pricing
  • Cash flow from operations increased $21.4M YoY to $48.0M
  • Free cash flow turned positive to $29.7M
  • Capital expenditures decreased $8.2M YoY to $18.3M

The bad

  • Adjusted EBITDA declined $10.1M YoY to $14.6M
  • Adjusted EPS declined $0.32 YoY to ($0.24)
  • Net income declined $4.9M YoY to ($7.6M)
  • Adjusted EBITDA margin compressed 320 bps YoY to 3.4%

The ugly

  • Reduced production output drove unfavorable fixed cost absorption in the quarter

Open questions

  • What specific actions are being taken to enhance cash generation and improve the cost position?
  • What is the status of the evaluation of the potential DEF growth project and Project CENTURY?
Full release

AdvanSix (ASIX) earnings release, November 4, 2026

AdvanSix Inc. (ASIX) · Form 8-K, Item 2.02 · Filed · SEC filing

News Release

ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

3Q26 Sales of $431 million, up 15% versus prior year

3Q26 Earnings Per Share of ($0.28); Adjusted Earnings Per Share of ($0.24)

3Q26 Cash Flow from Operations of $48 million, up $21 million versus prior year

Project CENTURY Selected for $47 million FIELDS Grant to Support Ammonia Platform Investment

Parsippany, N.J., November 4, 2026

- AdvanSix

(NYSE: ASIX), a vertically integrated chemistry company serving diverse end markets, today announced its financial results for the third quarter ending September 30, 2026.

Third Quarter 2026 Summary

"Our third quarter results reflect strong commercial execution and the resilience of our integrated business model as we navigate significant input cost inflation and a dynamic market environment,” said Erin Kane, president and CEO of AdvanSix. "We generated 15% sales growth year-over-year as our teams continued to leverage both formula and market-based pricing mechanisms to offset inflationary raw material costs. While our core caprolactam operating rate continues to exceed global industry averages, reduced production output drove unfavorable fixed cost absorption in the quarter. We are taking decisive actions to enhance cash generation, improve our cost position, and optimize our portfolio while continuing to prudently invest for attractive long-term growth opportunities. We remain focused on executing our strategic priorities and positioning AdvanSix to deliver sustainable long-term value."

Summary third quarter 2026 financial results for the Company are included below:¹

Financial statements

Income Statement

Summary third quarter 2026 financial results for the Company are included below: ($ in Thousands, Except Earnings Per Share)

3Q 20263Q 2025Variance $
Sales430,807374,47356,334
Net Income (Loss)-7,555-2,638-4,917
Diluted Earnings Per Share-0.28-0.1-0.18
Adjusted Diluted Earnings Per Share (1)-0.240.08-0.32
Adjusted EBITDA (1)14,64324,734-10,091
Adjusted EBITDA Margin % (1)3.4%6.6%(320) bps
Cash Flow from Operations47,96226,58821,374
Capital Expenditures18,27526,522-8,247
Free Cash Flow (1)(2)29,6876629,621

Income Statement

Three Months Ended September 30, — (Dollars in thousands, except share and per share amounts)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Sales430,807374,4731,256,2741,162,286
Costs, expenses and other:
Cost of goods sold419,602349,0881,210,1661,024,716
Selling, general and administrative expenses19,19627,42563,76876,250
Interest expense, net4,0272,3229,0656,119
Other non-operating income, net-890-815-1,573-1,831
Total costs, expenses and other441,935378,0201,281,4261,105,254
Income (loss) before taxes-11,128-3,547-25,15257,032
Income tax expense (benefit)-3,573-909-5,2994,955
Net income (loss)-7,555-2,638-19,85352,077
Earnings per common share
Basic-0.28-0.1-0.731.94
Diluted-0.28-0.1-0.731.91
Weighted average common shares outstanding
Basic27,077,10326,927,30527,035,09226,887,489
Diluted27,077,10326,927,30527,035,09227,248,759

Income Statement

Three Months Ended September 30, — Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

Three Months Ended September 30, – 2026Nine Months Ended September 30, – 2025Nine Months Ended September 30, – 20262025
Net income (loss)-7,555-2,638-19,85352,077
Non-cash stock-based compensation6751,6324,5535,919
Non-cash amortization from acquisitions5325321,5951,595
Strategic advisory and professional fees (2)4,0004,000
Income tax benefit relating to reconciling items-234-1,378-1,082-2,287
Adjusted Net income (loss) (non-GAAP)-6,5822,148-14,78761,304
Interest expense, net4,0272,3229,0656,119
Income tax expense (benefit) - Adjusted-3,339469-4,2167,242
Depreciation and amortization - Adjusted20,53719,79561,22557,371
Adjusted EBITDA (non-GAAP)14,64324,73451,287132,036
Sales430,807374,4731,256,2741,162,286
Adjusted EBITDA Margin (non-GAAP) (3)3.4%6.6%4.1%11.4%

Income Statement

Three Months Ended September 30, — Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net income (loss)-7,555-2,638-19,85352,077
Adjusted Net income (loss) (non-GAAP)-6,5822,148-14,78761,304
Weighted-average number of common shares outstanding - basic27,077,10326,927,30527,035,09226,887,489
Dilutive effect of equity awards and other stock-based holdings361,270
Weighted-average number of common shares outstanding - diluted27,077,10326,927,30527,035,09227,248,759
EPS - Basic-0.28-0.1-0.731.94
EPS - Diluted-0.28-0.1-0.731.91
Adjusted EPS - Basic (non-GAAP)-0.240.08-0.552.28
Adjusted EPS - Diluted (non-GAAP)-0.240.08-0.552.25

Balance Sheet

September 30, 2026 — (Dollars in thousands, except share and per share amounts)

September 30, 2026December 31, 2025
Current assets:
Cash and cash equivalents22,55019,766
Accounts and other receivables – net193,416154,102
Inventories – net181,413236,495
Taxes receivable22,78621,605
Other current assets14,8398,639
Total current assets435,004440,607
Property, plant and equipment – net962,786963,718
Operating lease right-of-use assets140,555164,494
Goodwill56,19256,192
Intangible assets37,80840,095
Other assets45,12941,042
Total assets1,677,4741,706,148
Current liabilities:
Accounts payable286,405284,016
Accrued liabilities31,41145,945
Income taxes payable551,100
Operating lease liabilities – short-term40,40944,354
Deferred income and customer advances1,58914,536
Current portion of long-term debt3,750
Total current liabilities363,619389,951
Deferred income taxes150,887154,061
Operating lease liabilities – long-term101,695121,201
Line of credit – long-term120,000215,000
Long-term debt144,727
Other liabilities11,13110,719
Total liabilities892,059890,932

Cash Flow

Three Months Ended September 30, — (Dollars in thousands)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Cash flows from operating activities:
Net income (loss)-7,555-2,638-19,85352,077
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization21,06920,32762,82058,966
(Gain) loss on disposal of assets12146-177
Deferred income taxes-1,2857,820-3,17414,466
Stock-based compensation6751,6324,5535,919
Amortization of deferred financing fees668155972464
Changes in assets and liabilities, net of business acquisitions:
Accounts and other receivables-6,243-24,977-39,584-38,971
Inventories12,73212,64455,0823,266
Taxes receivable-2,276-8,515-1,181-23,255
Accounts payable44,3384,12321,40416,546
Income taxes payable-18-335-1,045-998
Accrued liabilities-12,0888,352-14,0898,913
Deferred income and customer advances-391-1,177-12,947-36,857
Other assets and liabilities-1,6769,177-10,436-1,218
Net cash provided by operating activities47,96226,58842,66859,141
Cash flows from investing activities:
Expenditures for property, plant and equipment-18,275-26,522-74,925-88,849
Other investing activities-324-262-546-6,153
Net cash used for investing activities-18,599-26,784-75,471-95,002
Cash flows from financing activities:
Proceeds from long-term debt150,000150,000
Payment of debt issuance costs-1,549-1,549
Borrowings from line of credit106,00085,000367,500316,500
Repayments of line of credit-261,000-75,000-462,500-261,500
Payment of line of credit facility fees-2,877-2,877
Principal payments of finance leases-243-249-756-740
Dividend payments-4,320-4,296-12,947-12,876
Purchase of treasury stock-41-121-1,438-1,658
Issuance of common stock112154267
Net cash provided by (used for) financing activities-14,0305,44635,58739,993
Net change in cash and cash equivalents15,3335,2502,7844,132
Cash and cash equivalents at beginning of period7,21718,44619,76619,564
Cash and cash equivalents at the end of period22,55023,69622,55023,696
Supplemental non-cash investing activities:
Capital expenditures included in accounts payable8,31014,894

Cash Flow

Three Months Ended September 30, — Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net cash provided by operating activities47,96226,58842,66859,141
Expenditures for property, plant and equipment-18,275-26,522-74,925-88,849
Free cash flow (1)29,68766-32,257-29,708
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.

(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

(2) Net cash provided by operating activities less capital expenditures

Sales of $431 million in the quarter increased approximately 15% versus the prior year driven by 17% favorable pricing, partially offset by a 2% decline in volume. Raw material pass-through pricing was up 10% following a net cost increase in benzene and propylene (inputs to cumene which is a key feedstock to our products). Market-based pricing improved by 7% primarily reflecting an increase across all product lines and strong commercial execution amid a higher input cost environment. Lower sales volume was primarily driven by lower caprolactam sales.

Sales by product line and approximate percentage of total sales are included below:

Adjusted EBITDA of $14.6 million in the quarter decreased $10.1 million versus the prior year primarily driven by the unfavorable impact of reduced production output and higher raw material costs, partially offset by higher pricing and disciplined cost savings including our non-manpower fixed cost savings initiative.

Adjusted earnings per share of ($0.24) decreased $0.32 versus the prior year driven primarily by the factors discussed above.

Cash flow from operations of $48.0 million in the quarter increased $21.4 million versus the prior year² primarily due to disciplined working capital performance. Capital expenditures of $18.3 million in the quarter decreased $8.2 million versus the prior year, as expected, driven by continued risk-based prioritization of base investments and progression of growth projects including SUSTAIN.

Credit Agreement

On August 14, 2026, the Company completed a refinancing of its existing credit facility by entering into a new 5-year $425 million credit facility providing ample liquidity and capital deployment optionality. The new agreement is comprised of a $275 million senior secured revolving credit facility and a $150 million senior secured term loan facility.

Outlook

• Expect tighter ammonium sulfate supply and demand dynamics into 2027 amid challenged sulfur input cost environment

• Acetone spread over propylene costs expected to hold near cycle averages

• Continue to optimize Nylon Solutions price over raws spreads and sales volume mix in soft industrial end market environment

• Now expect Capital Expenditures of approximately $90 million in 2026 versus $116 million in 2025, reflecting risk-based prioritization of base investments and enterprise programs with continued progression of growth programs including SUSTAIN

• Continue to expect pre-tax income impact of plant turnarounds to be approximately $17 million in 2026 versus $25 million in 2025

• Continue to expect 2H 2026 sequential cash flow improvement primarily due to a reduced Capital Expenditures run-rate, working capital tailwinds including our 4Q 2026 pre-buy program in Plant Nutrients, and timing of annual payments paid in 1H 2026

"Looking ahead, we remain focused on navigating near-term market dynamics while strengthening our performance and positioning AdvanSix for the future. We are prioritizing disciplined cost management, cash generation and capital deployment while advancing our strategic growth initiatives. We will ensure a well-managed balance sheet as we continue to progress evaluation of our potential DEF growth project as well as Project CENTURY. In addition, our non-manpower fixed cost savings program remains on track while we continue to anticipate 45Q carbon capture tax credits to support improved earnings and cash flow generation moving forward," concluded Kane.

Dividend

The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on December 1, 2026 to stockholders of record as of the close of business on November 17, 2026.

Conference Call Information

AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international)³... (truncated)be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on November 4 until 12 noon ET on November 11 by dialing (855) 669-9658 (domestic) or (412) 317-0088 (international). The access code is 3522933.

About AdvanSix

AdvanSix is a vertically integrated chemistry company that produces essential materials for our customers across diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

Forward Looking Statements

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in the Middle East, as well as any related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with potential use of artificial intelligence in our operations or those of third party service providers; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those contemplated by such forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those identified in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, as updated in subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.⁴

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

# # #⁵

AdvanSix Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Dollars in thousands, except share and per share amounts)⁶

AdvanSix Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Dollars in thousands, except share and per share amounts)⁷

AdvanSix Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Dollars in thousands)⁸

AdvanSix Inc.

Non-GAAP Measures

(Dollars in thousands, except share and per share amounts)

Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share⁹

The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.¹⁰

AdvanSix Inc.

Appendix

(Pre-tax income impact, Dollars in millions)

Planned Plant Turnaround Schedule

(4)

(4)

Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

(5)

During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense and lost sales.

(6)

During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense, and lost sales.¹¹

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.